Titan Pharmaceuticals Inc. (TTNP)

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2020 Results - Earnings Call Transcript
May 16, 2020 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2019 Results - Earnings Call Transcript
March 30, 2020 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q3 2019 Results - Earnings Call Transcript
Nov. 15, 2019 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2019 Results - Earnings Call Transcript
Aug. 14, 2019 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2019 Results - Earnings Call Transcript
May 15, 2019 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2018 Results - Earnings Call Transcript
April 2, 2019 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q1 2018 Results - Earnings Call Transcript
May 16, 2018 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q4 2017 Results - Earnings Call Transcript
April 2, 2018 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q3 2017 Results - Earnings Call Transcript
Nov. 9, 2017 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q2 2017 Results - Earnings Call Transcript
Aug. 9, 2017 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q1 2017 Results - Earnings Call Transcript
May 12, 2017 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q4 2016 Results - Earnings Call Transcript
March 16, 2017 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q3 2016 Results - Earnings Call Transcript
Nov. 9, 2016 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q2 2016 Results - Earnings Call Transcript
Aug. 9, 2016 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q1 2016 Results - Earnings Call Transcript
May 10, 2016 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q4 2015 Results - Earnings Call Transcript
March 15, 2016 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals (TTNP) Q3 2015 Results - Earnings Call Transcript
Nov. 16, 2015 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) Q2 2015 Results - Earnings Call Transcript
Aug. 17, 2015 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceutical's (TTNP) Q1 2015 Results - Earnings Call Transcript
May 14, 2015 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' (TTNP) Q4 2014 Results - Earnings Call Transcript
April 1, 2015 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals (TTNP) Q3 2014 Results - Earnings Call Transcript
Nov. 14, 2014 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals (TTNP) Q2 2014 Results - Earnings Call Transcript
Aug. 14, 2014 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals (TTNP) Q1 2014 Results - Earnings Call Transcript
May 15, 2014 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' Management Discusses Q4 2013 Results - Earnings Call Transcript
April 1, 2014 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 15, 2013 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' Management Presents at Update Conference (Transcript)
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' Management Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
May 16, 2013 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' Management Discusses Q4 2012 Results - Earnings Call Transcript
March 18, 2013 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' CEO Discusses Q3 2012 Earnings Results - Earnings Call Transcript
Nov. 13, 2012 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 14, 2012 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Nov. 11, 2008 | Price: Free! | Source: Seeking Alpha

Titan Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript
Sept. 23, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Other definitive proxy statements - May 22, 2020

Titan Pharmaceuticals Inc. Just Filed Its Quarterly Report: 3.    Net Loss Pe... - May 15, 2020

Other preliminary proxy statements - May 12, 2020

Departure of Directors or Certain - April 24, 2020

Titan Pharmaceuticals Inc. Just Filed Its Annual Report: Net Loss Per Shar... - March 30, 2020

On March - March 19, 2020

As previously - March 16, 2020

Submission of Matters to a Vote of Security - March 2, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: EXPLANATORY NOTE - Feb. 24, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - Feb. 19, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - Feb. 12, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: PLEASE DO NOT IGNORE — YOUR VOTE IS EXTREMELY IMPORTANT VOTE TODAY Dear Titan Stockholder: - Jan. 31, 2020

Other definitive proxy statements - Jan. 31, 2020

Martin D. Hoe just provided an update on share ownership of Titan Pharmaceuticals Inc. - Jan. 27, 2020

Other preliminary proxy statements - Jan. 21, 2020

Submission of Matters to a Vote of Security - Jan. 16, 2020

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of Titan Pharmaceuticals Inc. - Jan. 13, 2020

Notice of Exempt Offering of Securities, item 06b - Jan. 9, 2020

Titan Pharmaceuticals Announces Pricing Of $2.2 Million Registered Direct Offering - Jan. 7, 2020

Titan Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 7, 2020

Prospectus [Rule 424(b)(5)] - Jan. 7, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - Dec. 31, 2019

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - Dec. 23, 2019

Submission of Matters to a Vote of Security - Dec. 20, 2019

Titan Pharmaceuticals: Highlights 3 Innovative & Proprietary Drug Delivery Platform Refocused Commercialization Strategy Large & Growing Market Opportunity Experienced Management Team - Dec. 10, 2019

Titan Pharmaceuticals Inc. releases salary data. CEO sees compensation fall -16% - Nov. 20, 2019

Titan Pharmaceuticals Inc. Just Filed Its Quarterly Report: 3.    Net Loss Pe... - Nov. 14, 2019

Other preliminary proxy statements - Nov. 4, 2019

Martin D. Hoe just provided an update on share ownership of Titan Pharmaceuticals Inc. - Oct. 22, 2019

Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering - Oct. 18, 2019

Prospectus [Rule 424(b)(5)] - Oct. 17, 2019

Titan Pharmaceuticals Inc. Just Received a Notice of Effectiveness - Oct. 16, 2019

General form for registration of securities under the Securities Act of 1933 - Oct. 11, 2019

General form for registration of securities under the Securities Act of 1933 - Oct. 8, 2019

General form for registration of securities under the Securities Act of 1933 - Sept. 27, 2019

Confidential treatment order - Sept. 20, 2019

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Sept. 20, 2019

Titan Pharmaceuticals: Titan Receives Approval For Second Year Of Nida Grant Funding For Development Of A Nalmefene Implant - Sept. 18, 2019

General form for registration of securities under the Securities Act of 1933 - Sept. 12, 2019

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Aug. 23, 2019

Notice of Exempt Offering of Securities, item 06b - Aug. 19, 2019

Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering - Aug. 8, 2019

Titan Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 8, 2019

Titan Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 8, 2019

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of Titan Pharmaceuticals Inc. - Aug. 7, 2019

On June - June 27, 2019

Titan Pharmaceuticals Inc.'s See Remarks was just granted 80,000 options - June 7, 2019

Titan Pharmaceuticals Inc. Just Filed Its Quarterly Report: 6.Subsequent Events ... - May 15, 2019

Entry into Material Definitive - April 26, 2019

Prospectus [Rule 424(b)(5)] - April 26, 2019

Titan Pharmaceuticals Inc. Just Received a Notice of Effectiveness - April 24, 2019

Registration statement under Securities Act of 1933 - April 16, 2019

Registration statement under Securities Act of 1933 - April 5, 2019

Titan Pharmaceuticals Inc.'s Executive Chairman was just granted 200,000 options - April 3, 2019

Titan Pharmaceuticals Inc.'s President and CEO was just granted 200,000 options - April 3, 2019

Departure of Directors or Certain - April 3, 2019

Titan Pharmaceuticals Inc. Just Filed Its Annual Report: 14. Subsequent Event... - April 2, 2019

Titan Pharmaceuticals Inc. Just Filed Its Annual Report: 14. Subsequent Event... - April 1, 2019

Departure of Directors or Certain - Feb. 25, 2019

Titan Pharmaceuticals Inc.'s Chief Scientific Officer just declared owning 2,387 shares of Titan Pharmaceuticals Inc. - Feb. 25, 2019

Titan Pharmaceuticals Inc.'s See Remarks just declared 41,667 options - Feb. 25, 2019

Regulation FD - Feb. 14, 2019

Titan Pharmaceuticals Announces Reverse Stock Split - Jan. 25, 2019

Titan Pharmaceuticals Inc. releases salary data. CEO sees compensation fall -16% - Dec. 20, 2018

Other preliminary proxy statements - Dec. 6, 2018

Current report, item 8.01 - Oct. 22, 2018

Titan Pharmaceuticals Inc. director just picked up 200,000 shares - Oct. 22, 2018

On October - Oct. 3, 2018

Titan Pharmaceuticals Inc. director just picked up 500,000 shares - Sept. 26, 2018

Titan Pharmaceuticals Inc.'s Executive Chairman just picked up 400,000 shares - Sept. 25, 2018

Titan Pharmaceuticals Inc. director just picked up 80,000 shares - Sept. 25, 2018

Titan Pharmaceuticals Inc. director just picked up 200,000 shares - Sept. 25, 2018

Titan Pharmaceuticals Inc. director just picked up 200,000 shares - Sept. 25, 2018

Titan Pharmaceuticals Prices $9,500,000 Public Offering - Sept. 25, 2018

Titan Pharmaceuticals Inc.'s See Remarks just picked up 300,000 shares - Sept. 25, 2018

Titan Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 25, 2018

Prospectus [Rule 424(b)(5)] - Sept. 24, 2018

Creation of Direct Financial Obligation or an Obligation under an - Sept. 20, 2018

General form for registration of securities under the Securities Act of 1933 - Sept. 20, 2018

Titan Pharmaceuticals Inc. Just Received a Notice of Effectiveness - Sept. 20, 2018

General form for registration of securities under the Securities Act of 1933 - Sept. 12, 2018

Filing under Securities Act Rules 163/433 of free writing prospectuses - Sept. 10, 2018

Titan Pharmaceuticals: Titan Awarded Nida Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse - Sept. 10, 2018

Titan Pharmaceuticals: Titan And The Nevada Center For Behavioral Health Collaborate To Evaluate Probuphine® Treament Of Oud Patients Within The State Of Nevada Criminal Justice System - Sept. 4, 2018

Filing under Securities Act Rules 163/433 of free writing prospectuses - Sept. 4, 2018

General form for registration of securities under the Securities Act of 1933 - Aug. 30, 2018

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Aug. 17, 2018

General form for registration of securities under the Securities Act of 1933 - Aug. 14, 2018

Submission of Matters to a Vote of Security - Aug. 8, 2018

Titan Pharmaceuticals: Titan Announces Amendment To Agreement With Molteni - Aug. 3, 2018

On July - July 31, 2018

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - June 1, 2018

Titan Pharmaceuticals And Braeburn Announce Mutual TERMINATION OF LICENSE AGREEMENT FOR PROBUPHINE® FOR OPIOID DEPENDENCE - May 30, 2018

Titan Pharmaceuticals Inc. director just declared owning 100,845 shares of Titan Pharmaceuticals Inc. - May 23, 2018

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - April 13, 2018

Confidential treatment order - April 2, 2018

Titan Pharmaceuticals Inc. Just Filed Its Annual Report: The following ta... - April 2, 2018

Titan Pharmaceuticals: Titan Executes Agreement For Acquisition By Molteni Of PROBUPHINE IN EUROPE AND OTHER SELECT TERRITORIES - March 26, 2018

Titan Pharmaceuticals Inc.'s Executive Chairman was just granted 170,000 options - March 9, 2018

Titan Pharmaceuticals Inc.'s President and CEO was just granted 170,000 options - March 9, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Robert E. Mead 1,754,546 N/A Nov. 10, 2015
2. VANGUARD GROUP INC 582,180 N/A June 30, 2019
3. SUSQUEHANNA INTERNATIONAL GROUP, LLP 559,184 N/A Dec. 31, 2019
4. Virtu Financial LLC 520,912 N/A Dec. 31, 2019
5. BlackRock Fund Advisors 513,014 N/A Sept. 30, 2016
6. GEODE CAPITAL MANAGEMENT, LLC 443,680 N/A March 31, 2020
7. MORGAN STANLEY 169,501 N/A Dec. 31, 2016
8. BlackRock Institutional Trust Company, N.A. 131,115 N/A Dec. 31, 2016
9. BlackRock Investment Management, LLC 71,414 N/A Dec. 31, 2016
10. ETRADE Capital Management LLC 61,000 N/A March 31, 2020
11. NORTHERN TRUST CORP 52,639 N/A March 31, 2018
12. BANK OF AMERICA CORP /DE/ 36,864 N/A Sept. 30, 2017
13. Raymond James Financial Services Advisors, Inc. 36,638 N/A March 31, 2020
14. Cornerstone Wealth Management, LLC 35,000 N/A March 31, 2020
15. HighTower Advisors, LLC 20,266 N/A March 31, 2020
16. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
17. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
18. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
19. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
20. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
21. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
22. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
23. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
24. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
25. NORTHERN TRUST CORP 15,023 N/A Dec. 31, 2019
26. BlackRock Advisors LLC 11,277 N/A Sept. 30, 2016
27. UBS Group AG 7,791 N/A March 31, 2019
28. UBS Group AG 7,791 N/A March 31, 2019
29. UBS Group AG 7,791 N/A March 31, 2019
30. UBS Group AG 7,791 N/A March 31, 2019

Titan Pharmaceuticals Inc. (TTNP)

140

cctranscripts

May 22, 2020

Other definitive proxy statements http://www.conferencecalltranscripts.org/pink/summary?id=7936539

cctranscripts

May 15, 2020

Titan Pharmaceuticals Inc. Just Filed Its Quarterly Report: 3.    Net Loss Pe... http://www.conferencecalltranscripts.org/pink/summary?id=7900061

cctranscripts

May 12, 2020

Other preliminary proxy statements http://www.conferencecalltranscripts.org/pink/summary?id=7876316

cctranscripts

April 24, 2020

Departure of Directors or Certain http://www.conferencecalltranscripts.org/pink/summary?id=7787353

cctranscripts

March 30, 2020

Titan Pharmaceuticals Inc. Just Filed Its Annual Report: Net Loss Per Shar... http://www.conferencecalltranscripts.org/pink/summary?id=7673016

cctranscripts

March 19, 2020

On March http://www.conferencecalltranscripts.org/pink/summary?id=7621199

cctranscripts

March 16, 2020

As previously http://www.conferencecalltranscripts.org/pink/summary?id=7599779

cctranscripts

March 2, 2020

Submission of Matters to a Vote of Security http://www.conferencecalltranscripts.org/pink/summary?id=7524438

cctranscripts

Feb. 24, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: EXPLANATORY NOTE http://www.conferencecalltranscripts.org/pink/summary?id=7483283

cctranscripts

Feb. 19, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: http://www.conferencecalltranscripts.org/pink/summary?id=7460849

cctranscripts

Feb. 12, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: http://www.conferencecalltranscripts.org/pink/summary?id=7413737

cctranscripts

Jan. 31, 2020

Titan Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: PLEASE DO NOT IGNORE — YOUR VOTE IS EXTREMELY IMPORTANT VOTE TODAY Dear Titan Stockholder: http://www.conferencecalltranscripts.org/pink/summary?id=7357575

cctranscripts

Jan. 31, 2020

Other definitive proxy statements http://www.conferencecalltranscripts.org/pink/summary?id=7357536

cctranscripts

Jan. 27, 2020

Martin D. Hoe just provided an update on share ownership of Titan Pharmaceuticals Inc. http://www.conferencecalltranscripts.org/pink/summary?id=7330913

cctranscripts

Jan. 21, 2020

Other preliminary proxy statements http://www.conferencecalltranscripts.org/pink/summary?id=7315920

cctranscripts

Jan. 16, 2020

Submission of Matters to a Vote of Security http://www.conferencecalltranscripts.org/pink/summary?id=7298053

cctranscripts

Jan. 13, 2020

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of Titan Pharmaceuticals Inc. http://www.conferencecalltranscripts.org/pink/summary?id=7282077

cctranscripts

Jan. 9, 2020

Notice of Exempt Offering of Securities, item 06b http://www.conferencecalltranscripts.org/pink/summary?id=7272017

cctranscripts

Jan. 7, 2020

Titan Pharmaceuticals Announces Pricing Of $2.2 Million Registered Direct Offering http://www.conferencecalltranscripts.org/pink/summary?id=7262859

cctranscripts

Jan. 7, 2020

Titan Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities http://www.conferencecalltranscripts.org/pink/summary?id=7262934
 


Feedback